| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Jefferies reiterates Supernus Pharmaceuticals stock Buy rating | ||
| Mo | Jefferies reiterates Grab stock rating on Taiwan foodpanda deal | ||
| Mo | Cantor Fitzgerald cuts Robinhood stock price target on revenue outlook | ||
| Mo | Barclays lowers Alvotech stock price target to $4 on approval timing | ||
| Mo | Kratos wins contract for SKY Perfect JSAT 5G satellite network | ||
| Mo | RBC Capital reiterates Ideaya Biosciences stock rating on trial delay | ||
| Mo | Guggenheim raises Cabaletta Bio stock price target on trial progress | ||
| Mo | OSB Group executives receive share-based compensation awards | ||
| Mo | Cantor Fitzgerald upgrades Coeur Mining stock rating to buy | ||
| Mo | Barclays reiterates Simon Property stock rating after CEO death | ||
| Mo | Allegiant offers fee-free changes amid government shutdown | ||
| Mo | BofA raises WeRide stock price target on overseas robotaxi growth | ||
| Mo | BofA raises Insmed stock price target on positive trial data | ||
| Mo | Guggenheim reiterates Buy rating on Avalo Therapeutics stock | ||
| Mo | Zillow becomes official MLB partner in multiyear deal | ||
| Mo | MaaT Pharma presents phase 3 trial results for aGvHD treatment | ||
| Mo | Barclays raises Viatris stock price target on pipeline potential | ||
| Mo | Stifel reiterates Buy rating on Limbach Holdings stock at $107 | ||
| Mo | Apogee Therapeutics stock holds at Hold as trial data beats views | ||
| Mo | BofA raises Northern Oil and Gas price target to $32 on leverage outlook | ||
| Mo | RBC Capital raises Insmed stock price target on ENCORE trial results | ||
| Mo | Apple schedules WWDC for June 8-12 with AI focus | ||
| Mo | Turkcell secures $1 billion Islamic financing for 5G rollout | ||
| Mo | Advent to sell 5.6% stake in Trustpilot via accelerated placing | ||
| Mo | Jefferies raises Pyxis Oncology stock price target on drug data |